Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2003
12/25/2003US20030236198 For treatment of infections by drug resistant bacteria
12/25/2003US20030235863 Bead-based detection of ligand-GPCR-G protein complexes
12/25/2003US20030234379 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
12/24/2003WO2003106628A2 Benzodiazepine inhibitors of mitochondial f>10< atp hydrolase and methods of inhibiting f>10< atp hydrolase
12/24/2003WO2003106452A2 Antagonists of melanin concentrating hormone receptor
12/24/2003WO2003106451A1 Substituted diaminopyrimidines
12/24/2003WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
12/24/2003WO2003106449A1 Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
12/24/2003WO2003106448A2 Novel herbicides
12/24/2003WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
12/24/2003WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003WO2003106429A1 Prodrug and process for producing the same
12/24/2003WO2003106427A2 Pyrazolecarboxamide insecticides
12/24/2003WO2003106426A1 Compounds, compositions, and methods
12/24/2003WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106417A1 Mitotic kinesin inhibitors
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106381A2 Human adam-10 inhibitors
12/24/2003WO2003105855A1 Mitotic kinesin inhibitors
12/24/2003WO2003105851A1 Novel crystalline forms of gatifloxacin
12/24/2003WO2003105850A1 2-aminoquinolines as melanin concentrating hormone receptor antagonists
12/24/2003WO2003105849A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
12/24/2003WO2003105847A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105845A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003WO2003105781A2 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
12/24/2003WO2003077892A3 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases
12/24/2003WO2003075926A8 Use of proton pump inhibitors for the treatment of airway disorders
12/24/2003WO2003074492A3 5-substituted-alkylaminopyrazole derivatives as pesticides
12/24/2003WO2003072548A8 Pyridyl sulfone derivatives as 5-ht receptor antagonists
12/24/2003WO2003070153A3 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/24/2003WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/24/2003WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
12/24/2003WO2003037886A3 Heteroaromatic carboxamide derivatives for the treatment of inflammation
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1131855C 1-取代-1-氨基甲基-环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CA2489470A1 Prodrug and process for producing the same
12/24/2003CA2489458A1 Substituted diaminopyrimidines
12/24/2003CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003CA2489377A1 Novel crystalline forms of gatifloxacin
12/24/2003CA2489367A1 Compounds, compositions, and methods
12/24/2003CA2489361A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2488802A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488407A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
12/24/2003CA2486215A1 Mitotic kinesin inhibitors
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667401 Method for producing heterocyclic compounds
12/23/2003US6667398 Reacting a benzamidine compound with a amide substituted pyrazole compound
12/23/2003US6667335 NMDA (N-methyl-D-aspartate)-receptor subtype selective blockers
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/23/2003US6667324 Dry blend pharmaceutical formulations
12/23/2003US6667323 Dry-blend pharmaceutical formulations
12/23/2003US6667322 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
12/23/2003US6667321 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
12/23/2003US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV)
12/23/2003US6667319 Neuropeptide Y Y5 receptor antagonists
12/23/2003US6667310 Insecticides
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003CA2059063C Novel antiviral compounds
12/18/2003WO2003104333A1 Yellow anionic disazo dyes
12/18/2003WO2003104332A1 Compositions and inks containing disazo dyes
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104221A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003WO2003104220A1 Asymetric synthesis of amino-pyrrolidinones
12/18/2003WO2003104206A2 Herbicidally active heterocyclylalkynes
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104196A1 Non-peptidic brs-3 agonists
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103668A1 Pyridin-2-one and quinolin-2-one derivatives, preparation thereof and use thereof as antibacterials
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103398A1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003082857A3 Lansoprazole polymorphs and processes for preparation thereof
12/18/2003WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
12/18/2003WO2003066593A3 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
12/18/2003WO2003053431A3 Pharmaceutical compositions based on azetidine derivatives
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003039440A3 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
12/18/2003WO2002064567A8 Substituted carboxamides as inhibitors of factor xa
12/18/2003WO2002060871A8 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors